ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research
Dr. van Koppen holds a Ph.D. in Pharmacology and brings extensive industry experience in drug discovery. Before joining ElexoPharm in January 2012, he served as Leader of four lead optimization projects at Merck Sharp & Dohme, The Netherlands. He was responsible for delivery of candidate drugs for preclinical development in endocrinological diseases. Dr. van Koppen was also strongly involved in assay development, HTS, lead finding and proof-of-concept projects. Before working at MSD, Dr. van Koppen was independent group leader at the Universitätsklinikum Essen and received his Habilitation in Pharmacology and Toxicology. He has published almost 70 peer-reviewed research papers, including publications in high IF journals (J Biol Chem, Endocrinology, J Clin Endocrinol Metab, PNAS, Mol Pharmacol, Br J Pharmacol, Thorax, Pharmacol Ther, and EMBO Journal).
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.